SAGD (South American Gold) Debt-to-EBITDA : -0.35 (As of Sep. 2013)


What is South American Gold Debt-to-EBITDA?

South American Gold SAGD -99.00% Debt-to-EBITDA is -0.35 as of Sep. 2013.

Debt-to-EBITDA measures a company's ability to pay off its debt.

South American Gold's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2013 was $0.05 Mil. South American Gold's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2013 was $0.02 Mil. South American Gold's annualized EBITDA for the quarter that ended in Sep. 2013 was $-0.19 Mil. South American Gold's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2013 was -0.35.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for South American Gold's Debt-to-EBITDA or its related term are showing as below:

SAGD's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.66
* Ranked among companies with meaningful Debt-to-EBITDA only.

South American Gold  (OTCPK:SAGD) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

South American Gold Debt-to-EBITDA Related Terms

South American Gold Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for South American Gold's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

South American Gold Debt-to-EBITDA Chart

South American Gold Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13
Debt-to-EBITDA
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -0.24

South American Gold Quarterly Data
Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.16 -0.68 -0.22 -0.35

SAGD vs RGGI, RAEWF: Debt-to-EBITDA Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, South American Gold's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

South American Gold Debt-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, South American Gold's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where South American Gold's Debt-to-EBITDA falls into.


South American Gold Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

South American Gold's Debt-to-EBITDA for the fiscal year that ended in Jun. 2013 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.04 + 0.019) / -0.25
=-0.24

South American Gold's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2013 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.046 + 0.019) / -0.188
=-0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2013) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -0.35 mean?
South American Gold (SAGD) has a Debt-to-EBITDA of -0.35 as of Sep. 2013. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on South American Gold.
Is South American Gold's Debt-to-EBITDA too high?
South American Gold's current Debt-to-EBITDA is -0.35.
How does South American Gold's Debt-to-EBITDA compare to RGGI and RAEWF?
South American Gold's Debt-to-EBITDA of -0.35 can be compared against companies in the Drug Manufacturers industry. The industry median Debt-to-EBITDA is 1.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Drug Manufacturers company?
The median Debt-to-EBITDA among Drug Manufacturers companies is 1.66, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on South American Gold. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. South American Gold's current Debt-to-EBITDA is -0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is South American Gold stock overvalued right now?
South American Gold (SAGD) has a current Debt-to-EBITDA of -0.35. The current Debt-to-EBITDA is -0.35. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For South American Gold (SAGD), the current Debt-to-EBITDA is -0.35 as of Sep. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

South American Gold Business Description

Address 8275 S. Eastern Avenue, Suite 200, Las Vegas, NV, USA, 89123
South American Gold Corp owns, operates, and invests in cannabis-related products, services, and technology. The company is focused on tech related as well as more traditional physical product operations that will provide a diverse base of products and service offerings.